Target intelligence / Profile preview

Solute carrier family 49 member 4 (SLC49A4)

Target
SLC49A4
Molecular classification
Transporter, Major facilitator superfamily, Membrane protein
01

Overview

Solute carrier family 49 member 4 (SLC49A4, also known as DIRC2) is a membrane protein belonging to the major facilitator superfamily of transporters[1][2][3]. It functions as an H+-driven lysosomal pyridoxine exporter, meaning it mediates the export of pyridoxine (vitamin B6) from lysosomes in a proton-dependent manner[4][5]. Disruption or chromosomal translocation of SLC49A4 causes haploinsufficiency and is associated with the development of hereditary and nonpapillary renal cell carcinoma[1][2][4]. SLC49A4 is encoded on chromosome 3, is highly conserved, and is expressed in several tissues including kidney, liver, and placenta[6]. No drugs directly targeting SLC49A4 are currently identified in public databases[1][9].

Other names
DIRC2Disrupted in renal carcinoma 2Disrupted in renal cancer protein 2RCC4FLJ14784renal cell carcinoma 4
02

Mechanism of action

H+-driven lysosomal pyridoxine export (by mutation or modulation of SLC49A4/DIIRC2 function)

03

Biological functions

Lysosomal pyridoxine (vitamin B6) exportH+-dependent (proton-coupled) transmembrane transportInvolved in cellular metabolite homeostasis
04

Disease associations

Cancer (particularly renal cell carcinoma)Hereditary conventional renal cell carcinoma
05

Safety considerations

Haploinsufficiency or genetic disruption is linked to predisposition for renal cancers
06

Biomarkers

Potential biomarker for renal cell carcinoma

Beyond the preview

Go deeper on Solute carrier family 49 member 4 (SLC49A4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 49 member 4 (SLC49A4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call